Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-015780
Filing Date
2010-02-23
Accepted
2010-02-23 16:46:57
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f55044e10vk.htm 10-K 1353305
2 EXHIBIT 10.18 f55044exv10w18.htm EX-10.18 29040
3 EX-10.22 f55044exv10w22.htm EX-10.22 440428
4 EX-21.1 f55044exv21w1.htm EX-21.1 1625
5 EX-23.1 f55044exv23w1.htm EX-23.1 9120
6 EX-31.1 f55044exv31w1.htm EX-31.1 7254
7 EX-31.2 f55044exv31w2.htm EX-31.2 7450
8 EX-32.1 f55044exv32w1.htm EX-32.1 5010
9 GRAPHIC f55044f5504401.gif GRAPHIC 10750
10 GRAPHIC f55044f5504402.gif GRAPHIC 4253
11 GRAPHIC f55044f5504403.gif GRAPHIC 2955
  Complete submission text file 0000950123-10-015780.txt   1879834
Mailing Address 2100 POWELL STREET EMERYVILLE CA 94608
Business Address 2100 POWELL STREET EMERYVILLE CA 94608 5105976500
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28298 | Film No.: 10626985
SIC: 2836 Biological Products, (No Diagnostic Substances)